Celldex Therapeutics buy stratec
Start price
08.12.17
/
50%
€40.32
Target price
16.04.18
€103.78
Performance (%)
-64.77%
End price
16.04.18
€14.21
Summary
This prediction ended on 16.04.18 with a price of €14.21. Massive losses of -64.77% were the result for the BUY prediction by stratec. stratec has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Celldex Therapeutics | 14.315% | 14.315% | 92.857% | -4.866% |
| iShares Core DAX® | 2,55 % | -0,11 % | 15,00 % | 49,60 % |
| iShares Nasdaq 100 | 2,74 % | -0,47 % | 30,95 % | 80,87 % |
| iShares Nikkei 225® | 6,58 % | 3,22 % | 49,70 % | 60,37 % |
| iShares S&P 500 | 1,93 % | -0,52 % | 24,88 % | 60,00 % |
Comments by stratec for this prediction
In the thread Celldex Therapeutics diskutieren
stratec stimmt der Outperform-Einschätzung der institutionellen Analysten zu
stratec stimmt am 08.12.2017 der Outperform-Einschätzung der institutionellen Analysten mit dem Kursziel 7.67$ zu.
Celldex (NASDAQ:CLDX) resumed with Strong Buy rating and $10 (250% upside) price target by WBB Securities.
(Vom Mitglied beendet)